Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02447861

The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

Status
Recruiting
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The 3q29 deletion syndrome is caused by a deletion of a small part of human chromosome 3, and the duplication syndrome is caused by a duplication of this same small region. The purpose of this study is to understand the medical and behavioral consequences of these syndromes.

Detailed description

People with 3q29 deletion syndrome are missing a small part of a region on human chromosome 3, and people with 3q29 duplication syndrome have an extra part of their chromosome 3. Sometimes babies are born with a deletion or duplication of part of human chromosome 3, even though their parents have an intact chromosome 3. This is called de novo (or new) abnormalities.

Conditions

Timeline

Start date
2013-07-01
Primary completion
2028-01-01
Completion
2028-01-01
First posted
2015-05-19
Last updated
2024-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02447861. Inclusion in this directory is not an endorsement.

The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes (NCT02447861) · Clinical Trials Directory